UBC Review Highlights Medicines as an Overlooked Cause of Ankle Swelling

A June 18 Therapeutics Initiative review urges clinicians to consider medicines when evaluating new peripheral edema. Its implications extend to community and hospital medication reviews across Canada.

Key takeaways

Calcium-channel blockers, gabapentinoids and non-prescription anti-inflammatory drugs are among the possible contributors. Mechanism matters: adding a diuretic may not address vasodilation-related swelling and can create a prescribing cascade.

Practice guidance for pharmacists

• Ask about new medicines and recent dose increases.
• Include over-the-counter products in the history.
• Document when swelling began relative to treatment changes.
• Discuss a suspected medication cause with the treating clinician, alongside assessment for other causes.
• Agree on monitoring after any clinically appropriate treatment adjustment.

This is an evidence review, not a new regulatory requirement. Swelling should not automatically be attributed to a medicine, and patients should not stop treatment solely on the basis of this article.